{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T07:21:54Z","timestamp":1795159314838,"version":"4.10.3"},"reference-count":104,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,8,3]],"date-time":"2009-08-03T00:00:00Z","timestamp":1249257600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vox Sanguinis"],"published-print":{"date-parts":[[2009,10]]},"abstract":"<jats:p>\n                    <jats:bold>Background\u2002<\/jats:bold>\n                    The quantity of iron in body is carefully regulated, primarily by control of iron absorption, and excess total body iron can be extremely toxic. Since humans have no mechanism for elimination of excess iron, multiple transfusions of red blood cells, which are required for the management of a number of disorders, inevitably result in iron overload. Cumulative iron overload, in turn, leads to iron toxicity with organ dysfunction and damage.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Materials\u2002<\/jats:bold>\n                    This review examines the relationship between iron metabolism and hematologic disorders treated with multiple transfusions, with emphasis on the diagnosis and current methods of management of iron overload and toxicity in transfusion\u2010dependent patients. Primarily using key words, we identified and reviewed more than 100 pertinent articles in English and other languages in the Medline database plus an additional number of abstracts of presentations at recent meetings of relevant scientific associations.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results\u2002<\/jats:bold>\n                    Transfusion\u2010dependent disorders include those characterized by decreased red blood cell production, increased red blood cell destruction, or chronic blood loss. Patients receiving chronic transfusion therapy should be screened and monitored for iron overload, yet in our opinion, this is not always done routinely. Once iron overload has been identified, it should be treated to reduce the risk of morbidity and mortality from iron toxicity, which particularly affects the liver and heart.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion\u2002<\/jats:bold>\n                    Increased awareness of the risks of iron overload from chronic transfusion therapy should result in greater use of interventions such as iron chelation to reduce total body iron and the risk of long\u2010term sequelae.\n                  <\/jats:p>","DOI":"10.1111\/j.1423-0410.2009.01207.x","type":"journal-article","created":{"date-parts":[[2009,8,3]],"date-time":"2009-08-03T05:11:04Z","timestamp":1249276264000},"page":"185-197","source":"Crossref","is-referenced-by-count":200,"title":["Iron overload and toxicity: the hidden risk of multiple blood transfusions"],"prefix":"10.1111","volume":"97","author":[{"given":"A.","family":"Shander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. D.","family":"Cappellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. T.","family":"Goodnough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,9,24]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2004.04.036"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199912233412607"},{"issue":"1","key":"e_1_2_7_4_2","first-page":"7","article-title":"Pathophysiology of iron overload","volume":"19","author":"Porter J","year":"2005","journal-title":"Hematol Oncol Clin"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0037-1963(01)90054-X"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-138-8-200304150-00008"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.2174\/0929867033457566"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.03195.x"},{"key":"e_1_2_7_9_2","volume-title":"The Management of Sickle Cell Disease","author":"National Heart, Lung, and Blood Institute","year":"2002"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200205000-00013"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.3.739"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199409013310903"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20685"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp078101"},{"key":"e_1_2_7_15_2","first-page":"791","article-title":"The role of hepcidin and ferroportin in iron absorption","volume":"22","author":"Oates PS","year":"2007","journal-title":"Histol Histopathol"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i35.4716"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006070802"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-12-077388"},{"key":"e_1_2_7_19_2","first-page":"43","article-title":"Anemia of chronic disease","volume":"352","author":"Goodnough LT","year":"2005","journal-title":"N Engl J Med"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3495(98)77983-4"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2007.01.042"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81151-4"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra031573"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1053\/shem.2002.35638"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0070-2153(07)00006-3"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.41.762"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(07)70459-9"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1989.29990070188.x"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncpendmet0702"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1423-0410.2002.00153.x"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1345.074"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-008-0120-5"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0037-1963(01)90058-7"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21317"},{"key":"e_1_2_7_35_2","doi-asserted-by":"crossref","unstructured":"SanzG NomdedeuB SuchE BernalT BelkaidM ArdanazMT MarcoV PedroC RamosF Del Ca\u00f1izoMC Lu\u00f1oE CoboF CarbonellF GomezV Mu\u00f1ozJA AmigoML BailenA BonadadS TormoM AndreuR ArrizabalagaB ArillaMJ BuenoJ RequenaMJ BargayJ SanchezJ SenentL ArenillasL De PazR XicoyB DuarteR CerveraJ:Independent impact of iron overload and transfusion dependency on survival and leukemic evolution in patients with myelodysplastic syndrome. Presented at the Annual Meeting of the American Society of Hematology. December 6\u20139 2008; San Francisco California. Abstract 640","DOI":"10.1182\/blood.V112.11.640.640"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1987.tb01291.x"},{"key":"e_1_2_7_37_2","first-page":"5","article-title":"Normal iron metabolism and the pathophysiology of overload disorders","volume":"27","author":"Siah CW","year":"2006","journal-title":"Clin Biochem Rev"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(86)80832-0"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0676.1986.tb00297.x"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.01144.2001"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-005-0029-x"},{"key":"e_1_2_7_42_2","first-page":"1187","article-title":"Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine","volume":"89","author":"Borgna\u2010Pignatti C","year":"2004","journal-title":"Haematologica"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp048266"},{"key":"e_1_2_7_44_2","first-page":"1588","article-title":"Predicting survival and leukemic evolution in patients with myelodysplastic syndrome","volume":"91","author":"Malcovati L","year":"2006","journal-title":"Haematologica"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2405070"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-10-054924"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00144623"},{"key":"e_1_2_7_48_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.86.5.344"},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.1.17"},{"key":"e_1_2_7_50_2","first-page":"1179","article-title":"Clinical and histological characterization of liver disease in patients with transfusion\u2010dependent beta\u2010thalassemia. A multicenter study of 117 cases","volume":"89","author":"Prati D","year":"2004","journal-title":"Haematologica"},{"key":"e_1_2_7_51_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00877096"},{"key":"e_1_2_7_52_2","first-page":"464","article-title":"Secondary hemochromatosis in polytransfused patients with myelodysplastic syndrome","volume":"30","author":"Jaeger M","year":"1992","journal-title":"Beitr Infusionsther"},{"key":"e_1_2_7_53_2","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1345.047"},{"key":"e_1_2_7_54_2","first-page":"636","article-title":"Clinical and economic consequences of myelodysplastic syndromes in the United States","volume":"112","author":"Goldberg SL","year":"2008","journal-title":"An Anal Med Database Blood (ASH Annual Meeting Abstracts)"},{"key":"e_1_2_7_55_2","first-page":"109","article-title":"Endocrine complications in transfusion dependent thalassaemia in Penang Hospital","volume":"63","author":"Ong CK","year":"2008","journal-title":"Med J Malaysia"},{"key":"e_1_2_7_56_2","first-page":"646","article-title":"Endocrine complications in patients with thalassaemia major","volume":"5","author":"Toumba M","year":"2007","journal-title":"Pediatr Endocrinol Rev"},{"key":"e_1_2_7_57_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06332.x"},{"key":"e_1_2_7_58_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780340314"},{"key":"e_1_2_7_59_2","first-page":"409","article-title":"Patients with thalassemia develop osteoporosis, osteomalacia, and hypoparathyroidism, all of which are corrected by transfusion","volume":"23","author":"Christenson RA","year":"1987","journal-title":"Birth Defects Orig Artic Series"},{"key":"e_1_2_7_60_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05143.x"},{"key":"e_1_2_7_61_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00690984"},{"key":"e_1_2_7_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(86)92869-0"},{"key":"e_1_2_7_63_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1991.00400080096018"},{"key":"e_1_2_7_64_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.4.2723"},{"key":"e_1_2_7_65_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830420116"},{"key":"e_1_2_7_66_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1989.tb01411.x"},{"key":"e_1_2_7_67_2","first-page":"895","article-title":"Diagnostic efficacy of screening tests for hereditary hemochromatosis","volume":"131","author":"Borwein S","year":"1984","journal-title":"Can Med Assoc"},{"key":"e_1_2_7_68_2","doi-asserted-by":"publisher","DOI":"10.1081\/HEM-120028886"},{"key":"e_1_2_7_69_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2004.00371.x"},{"key":"e_1_2_7_70_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb08428.x"},{"key":"e_1_2_7_71_2","doi-asserted-by":"publisher","DOI":"10.1002\/stem.150291"},{"key":"e_1_2_7_72_2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/clinchem\/44.1.40","article-title":"Serum transferrin receptors are decreased in the presence of iron overload","volume":"44","author":"Khumalo H","year":"1998","journal-title":"Clin Chem"},{"key":"e_1_2_7_73_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-03-0807"},{"key":"e_1_2_7_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2005.03.008"},{"key":"e_1_2_7_75_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-007-0604-y"},{"key":"e_1_2_7_76_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004424-199204000-00012"},{"key":"e_1_2_7_77_2","first-page":"1278","article-title":"Noninvasive in\u2010vivo measurement of hepatic and cardiac iron","volume":"33","author":"Wielopolski L","year":"1992","journal-title":"J Nuc Med"},{"key":"e_1_2_7_78_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.04838.x"},{"key":"e_1_2_7_79_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-10-3982"},{"key":"e_1_2_7_80_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-02-002394"},{"key":"e_1_2_7_81_2","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.2001.2822"},{"key":"e_1_2_7_82_2","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.168.5.9129412"},{"key":"e_1_2_7_83_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.193.2.7972774"},{"key":"e_1_2_7_84_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-01-0177"},{"key":"e_1_2_7_85_2","doi-asserted-by":"publisher","DOI":"10.1080\/10976640600698155"},{"key":"e_1_2_7_86_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.12513"},{"key":"e_1_2_7_87_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1754.1998.00276.x"},{"key":"e_1_2_7_88_2","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1345.043"},{"key":"e_1_2_7_89_2","doi-asserted-by":"crossref","unstructured":"WeigandK WeigandK:Percutaneous liver biopsy: retrospective study over 15 years comparing 287 in patients with 428 outpatients.J Gastroenterol Hepatol2009;February 4 [Epub ahead of print]","DOI":"10.1111\/j.1440-1746.2008.05718.x"},{"key":"e_1_2_7_90_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199409013310902"},{"key":"e_1_2_7_91_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840060106"},{"key":"e_1_2_7_92_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-06-1704"},{"key":"e_1_2_7_93_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(87)80124-9"},{"key":"e_1_2_7_94_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-008-0118-z"},{"key":"e_1_2_7_95_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.12413"},{"key":"e_1_2_7_96_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.24783"},{"key":"e_1_2_7_97_2","unstructured":"National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology \u2013 v.1.2009: Myelodysplastic Syndromes. Accessed on December 19 2008 at:http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/mds.pdf"},{"issue":"1","key":"e_1_2_7_98_2","first-page":"18","article-title":"Consensus statement on iron overload in myelodysplastic syndromes","volume":"19","author":"Gattermann N","year":"2005","journal-title":"Hematol Oncol Clin"},{"key":"e_1_2_7_99_2","first-page":"374","article-title":"Iron chelation therapy in patients with myelodysplastic syndromes: consensus conference guidelines","volume":"10","author":"Mittelman M","year":"2008","journal-title":"Isr Med Assoc J"},{"key":"e_1_2_7_100_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(07)70461-7"},{"key":"e_1_2_7_101_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0268-960X(08)70007-9"},{"key":"e_1_2_7_102_2","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2006.1.42"},{"key":"e_1_2_7_103_2","doi-asserted-by":"crossref","unstructured":"CappelliniMD El\u2010BeshlawyA KattamisA LeeJW SeymourJF LiC\u2010K HabrD DomokosG HmissiA ElalfyMS:Efficacy and safety of deferasirox (Exjade\u00ae) in patients with transfusion\u2010dependent anemias: 1\u2010year results from the large prospective multicenter EPIC study. Presented at the Annual Meeting of the American Society of Hematology. December 6\u20139 2008; San Francisco California. Poster III\u2010957","DOI":"10.1182\/blood.V112.11.3875.3875"},{"key":"e_1_2_7_104_2","unstructured":"PennellD SutcharitchanP El\u2010BeshlawyA AydinokY TaherA SmithG HabrD Kriemler\u2010KrahnU HmissiA PorterJB:Efficacy and safety of deferasirox (Exjade\u00ae) in preventing cardiac iron overload in\u03b2\u2010thalassemia patients with normal baseline cardiac iron: results from the cardiac substudy of the EPIC trial. Presented at the Annual Meeting of the American Society of Hematology. December 6\u20139 2008; San Francisco California. Poster III\u2010956"},{"key":"e_1_2_7_105_2","unstructured":"Desferal Prescribing Information. Accessed on December 19 2008 at:http:\/\/www.fda.gov\/cder\/foi\/label\/2001\/16267s34lbl.pdf"}],"container-title":["Vox Sanguinis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1423-0410.2009.01207.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1423-0410.2009.01207.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T15:01:14Z","timestamp":1697295674000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1423-0410.2009.01207.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,24]]},"references-count":104,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["10.1111\/j.1423-0410.2009.01207.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1423-0410.2009.01207.x","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1166933.629027","asserted-by":"object"}]},"ISSN":["0042-9007","1423-0410"],"issn-type":[{"value":"0042-9007","type":"print"},{"value":"1423-0410","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,24]]}}}